Amgen Inc (NASDAQ:AMGN) under-valued by 11%
| Website | http://www.amgen.com |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2019 |
| Market Cap | $126,732,476,000 |
| Beta | 0.73743 |
| Average Volume | $2,671,569 |
| Last Dividend | 6.1% |
| Price on Jul 29, 2020 | $216.38 |
| Autochartist™ Valuation | $240.18 |
| Conclusion |
11% under-valued |
| Download Report |
